The OncLive® Conference page includes a listing of all conferences covered by OncLive®, including the ASCO, ESMO, SITC, EHA, ASH, and SABCS annual meetings, as well as the Chemotherapy Foundation Symposium and Miami Breast Cancer Conference, among many others. Conference coverage incorporates articles and interviews in written and video format.
March 15th 2012, 6:00am
PER® Miami Breast Cancer Conference
Pictures from the Annual Miami Breast Cancer Conference, at the Fontainebleau Miami Beach hotel, in Florida.
March 14th 2012, 6:27am
PER® Miami Breast Cancer Conference
Debu Tripathy, MD, culled the highlights from abstracts presented in 2011 at the ASCO annual meeting in Chicago, Illinois, and at the CCTR-AARC SABCS in Texas.
March 14th 2012, 5:55am
PER® Miami Breast Cancer Conference
The impact of molecular and genomic advancements on the treatment of patients with breast cancer will be among the prime topics of discussion.
March 12th 2012, 1:34pm
PER® Miami Breast Cancer Conference
As the Miami Breast Cancer Conference enters its 29th year, Osman continues to organize the gathering and pack the 4-day meeting with faculty speakers.
February 27th 2012, 4:11pm
Hematologic Malignancies Congress
Dr. David Steensma, from Dana-Farber Cancer Institute, Discusses Iron Chelation Therapy for MDS
February 27th 2012, 12:50pm
Hematologic Malignancies Congress
Certain characteristics of patients with CML can affect therapeutic outcomes.
February 27th 2012, 12:17pm
Hematologic Malignancies Congress
A number of prognostic factors can help identify those at a high risk for CLL progression who may benefit from early intervention.
February 27th 2012, 10:34am
Hematologic Malignancies Congress
Dr. Harry Erba, from the University of Michigan Health System, Describes Proper Diagnostic Testing of CML
February 25th 2012, 3:22pm
Oncology Nursing Society Congress
Meeting coverage from the 2012 Oncology Nursing Society Congress held at the New Orleans Ernest N. Morial Convention Center, from May 3-6, 2012.
February 24th 2012, 4:28pm
Hematologic Malignancies Congress
Dr. Kieron Dunleavy from the National Cancer Institute Discusses 3 Molecular Subtypes of DLBCL
February 24th 2012, 2:34pm
Hematologic Malignancies Congress
A number of studies suggest that there is a right and wrong way to proceed with initial therapy and transplant eligibility for patients with multiple myeloma.
February 24th 2012, 9:40am
Hematologic Malignancies Congress
Research has shown that DLBCL is heterogeneous, suggesting that patients with varying subtypes should receive different courses of treatment.
February 24th 2012, 9:39am
Hematologic Malignancies Congress
Dr. Stephen Ansell from the Mayo Clinic Describes Waldenström Macroglobulinemia
January 26th 2012, 3:23pm
Updates From the ICHG/ASHG 61st Annual Meeting
The treatment of Gaucher disease is poised to enter a new era as a result of advances in the understanding of the cellular pathways at work in the disorder.
January 21st 2012, 3:45pm
Updates From the ICHG/ASHG 61st Annual Meeting
Rogerio Vivaldi, MD, has vivid memories of the first patient with Gaucher disease ever treated in Brazil with enzyme replacement therapy.
January 18th 2012, 3:03pm
Updates From the ICHG/ASHG 61st Annual Meeting
The mood of the ICHG/ASHG 2011 congress often seemed buoyant as researchers discussed the doors that technology is helping to open.
January 14th 2012, 4:09pm
Updates From the ICHG/ASHG 61st Annual Meeting
Dr. Gregory Grabowski, from the University Cincinnati, Explains the Effects of Enzyme Therapy
January 11th 2012, 3:10pm
Updates From the ICHG/ASHG 61st Annual Meeting
Pramod K. Mistry, MD, PhD, from Yale University, discusses Gaucher disease
December 13th 2011, 4:27pm
ASH Annual Meeting and Exposition
Dr. Anthony Mato From the John Theurer Cancer Center Discusses the Benefits of the JTCC Retrospective Trial
December 13th 2011, 4:06pm
ASH Annual Meeting and Exposition
A collection of photos from the ASH 53rd annual meeting at the San Diego Convention Center in San Diego, CA, from December 10-13, 2011.